Surgical Science Q3 2024: Sequential improvements continue - Redeye

Redeye updates its estimates following Surgical Science’s Q3 2024 report, which beat our expectations. Educational Products continued its sequential recovery, while solid Industry/OEM sales matched our projections. We expect a seasonally strong fourth quarter and solid growth in 2025e. We nudge up our estimates and valuation.

Länk till analysen i sin helhet: https://www.redeye.se/research/1056968/surgical-science-q3-2024-sequential-improvements-continue?utm_source=finwire&utm_medium=RSS